[Use of the beta-receptor blockader Iproveratril in the therapy of thyreotoxic crisis].
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001794:Blood Pressure; D001831:Body Temperature; D002395:Catecholamines / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009570:Nitriles / Q000627:therapeutic use*; D011674:Pulse; D013565:Sympatholytics / Q000627:therapeutic use; D013958:Thyroid Crisis / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014700:Verapamil / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D002395:Catecholamines; D009570:Nitriles; D013565:Sympatholytics; D014665:Vasodilator Agents; D014700:Verapamil
Die Anwendung des beta-Rezeptorenblockers Iproveratril in der Therapie der thyreotoxischen Krise.